Back to top
more

ConforMIS, Inc. (CFMS)

(Delayed Data from NSDQ)

$2.66 USD

2.66
1,165,738

+0.22 (9.02%)

Updated May 3, 2019 04:00 PM ET

After-Market: $2.65 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Conformis Next-Generation Identity PS Knee System Gets FDA Nod

by Zacks Equity Research

Conformis' (CFMS) latest iTotal Identity PS Knee System clears FDA hurdle, paving the way for providing better patient-specific pre-operative surgical plans.

ConforMIS (CFMS) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

ConforMIS (CFMS) delivered earnings and revenue surprises of -55.56% and -13.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

by Zacks Equity Research

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress

by Zacks Equity Research

Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress

Sanghamitra Saha headshot

What Bargain Hunting? Tap 5 Stocks With Rising P/E

by Sanghamitra Saha

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

Sanghamitra Saha headshot

Buy 5 Top-Ranked Stocks With Rising P/E

by Sanghamitra Saha

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

    ConforMIS (CFMS) Reports Q4 Loss, Lags Revenue Estimates

    by Zacks Equity Research

    ConforMIS (CFMS) delivered earnings and revenue surprises of 20.00% and -0.09%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

    Sweta Killa headshot

    5 Stocks That Pushed Russell 2000 ETF Higher

    by Sweta Killa

    Inside the best performing stocks of the Russell 2000 ETF.

    ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates

    by Zacks Equity Research

    ConforMIS (CFMS) delivered earnings and revenue surprises of -18.18% and -2.77%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

    Will ConforMIS (CFMS) Report Negative Earnings Next Week? What You Should Know

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Company News For Oct 2, 2019

    by Zacks Equity Research

    Companies In The News Are: ROAN, CFMS, NERV, REED

    ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 1.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

    ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Sweta Killa headshot

    Hottest Wall Street Stories of First Half

    by Sweta Killa

    We discuss some of the events that dominated the headlines in the first half and influenced the market.

    ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    ConforMIS (CFMS) delivered earnings and revenue surprises of 0.00% and 2.64%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

    Can iTotal PS Revenues Drive ConforMIS' (CFMS) Q1 Earnings?

    by Zacks Equity Research

    ConforMIS (CFMS) expects to register solid revenue growth on robust performance by its product lines as well as steady royalties.

    ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    ConforMIS (CFMS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Is ConforMIS (CFMS) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (CFMS) Outperforming Other Medical Stocks This Year?

    Will ConforMIS (CFMS) Report Negative Earnings Next Week? What You Should Know

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Is ConforMIS (CFMS) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (CFMS) Outperforming Other Medical Stocks This Year?

    Globus Medical (GMED) Surges: Stock Moves 7.1% Higher

    by Zacks Equity Research

    Globus Medical (GMED) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

    ConforMIS (CFMS) Reports Q3 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    ConforMIS (CFMS) delivered earnings and revenue surprises of 40.00% and 50.92%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

    ConforMIS (CFMS) Q3 Earnings Preview: How Are Events Shaping Up?

    by Zacks Equity Research

    ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS

    by Zacks Equity Research

    Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS